Azerbaijan vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Syrian Arab Republic
100.0%
in 2021
Azerbaijan rank
1st
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Syrian Arab Republic
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
Azerbaijan ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.5% | 100.0% | 25.5% | Syrian Arab Republic |
| 2020s | 95.5% | 100.0% | 4.5% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Syrian Arab Republic?
- Azerbaijan, at 100.0% against 100.0% in Syrian Arab Republic as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Syrian Arab Republic?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Syrian Arab Republic?
- 10 years are reported by both, from 2011 to 2021.
- How do Azerbaijan and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.